Equitec Proprietary Markets’s Acceleron Pharma XLRN Stock Holding History

Equitec Proprietary Markets’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-43,293	Closed	-$7.45M	–	496
2021 Q3	$7.45M	Buy	+43,293	New	+$5.66M	1.38%	13

Equitec Proprietary Markets's XLRN Position: Q4 2021 in Review

Equitec Proprietary Markets sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 43,293 shares — an estimated $7.45M sold.

Equitec Proprietary Markets first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $7.45M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Equitec Proprietary Markets reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Equitec Proprietary Markets sold 43,293 Acceleron Pharma shares in Q4 2021, an estimated $7.45M.
Equitec Proprietary Markets first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Equitec Proprietary Markets's Acceleron Pharma position peaked at $7.45M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Equitec Proprietary Markets's 13F filing for Q4 2021, filed 31 Jan 2022.